Table 3.
Publicly insured patientsa | Privately insured patientsa | Privately and Publicly insured patients at different momentsa | |
---|---|---|---|
Characteristic | n (%) | n (%) | n (%) |
N | 2 283 (100) | 8 971 (100) | 1 316 (100) |
Sex | |||
Female | 1 639 (71·8) | 6 338 (70·6) | 935 (71·1) |
Male | 644 (28·2) | 2 633 (29·4) | 381 (28·9) |
Age (years) when patients filled their last prescription | |||
0–18 | 94 (4·1) | 520 (5·8) | 54 (4·1) |
18–40 | 598 (26·2) | 2 707 (30·2) | 368 (28·0) |
40–65 | 1 591 (69·7) | 5 744 (64·0) | 894 (67·0) |
Year of enrolment in reMed | |||
2008–2014 | 1 717 (75·2) | 7 325 (81·7) | 1 075 (81·7) |
2015–2019 | 566 (24·8) | 1 646 (18·3) | 241 (18·3) |
Number of prescriptions filled per patienta (mean (SD)) | 17·5 (32·5) | 9·7 (16·4) | 26·3 (38·7) |
Number of different molecules filled per patienta (mean (SD)) | 2·6 (2·2) | 1·7 (1·2) | 3·7 (2·6) |
Number of pharmacies per patienta (mean (SD)) | 1·3 (0·7) | 1·2 (0·4) | 1·5 (0·8) |
SD standard deviation
a During study period between 1 January 2015 and 23 May 2019